Financial Year |
March 31 2023 |
Monetary Funds |
258,487,702.32 |
Held-for-trading Financial Assets |
66,000,000.00 |
Notes Receivable |
-- |
Accounts Receivable |
89,213,436.12 |
Advances to Suppliers |
13,315,354.59 |
Other Receivables |
78,200,290.52 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
-- |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
19,106,115.55 |
Other Current Assets |
19,414,260.92 |
Total Current Assets |
543,737,160.02 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
95,038,763.95 |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
4,964,239.66 |
Under-construction Projects |
3,221,295.51 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
5,464,112.17 |
R&D expenses |
-- |
Goodwill |
126,374,047.60 |
Long-Term Deferred and Prepaid Expenses |
840,425,888.74 |
Deferred Income Tax Assets |
172,444,193.77 |
Other Non-Current Assets |
222,270,435.44 |
Sub-Total of Non-Current Assets |
5,271,470,890.97 |
Total Assets |
5,815,208,050.99 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
129,489,369.90 |
Accounts Received In Advance |
49,768,512.82 |
Employee Compensation Payable |
10,763,352.00 |
Taxes Payable |
22,964,311.05 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
493,768,091.25 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
326,845,097.20 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
1,036,736,992.42 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
113,677,211.93 |
Other Non-Current Liabilities |
1,897,488.96 |
Sub-Total of Non-Current Liabilities |
3,546,782,146.19 |
Total Liabilities |
4,583,519,138.61 |
Paid-In Capital(Or Share Stock) |
472,500,000.00 |
Capital Surplus |
600,473,486.45 |
Surplus Reserve |
108,628,376.51 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-34,347,311.84 |
Minority Stockholder's Interest |
84,434,361.26 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,147,254,551.12 |
Owner's Equity(Stockholder's Equity) |
1,231,688,912.38 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,815,208,050.99 |